Cargando…
Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapeutic option for many patients with hematological malignancies and nonmalignant hematopoietic disorders. To achieve stable engraftment of donor hematopoietic stem cells (HSCs), recipient HSC deletion is needed to crea...
Autores principales: | Saha, Asim, Blazar, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632731/ https://www.ncbi.nlm.nih.gov/pubmed/36341432 http://dx.doi.org/10.3389/fimmu.2022.1031334 |
Ejemplares similares
-
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016) -
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020) -
The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
por: Ktena, Yiouli P., et al.
Publicado: (2023) -
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016) -
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
por: Bordat, Jonathan, et al.
Publicado: (2023)